Integrating RCTs, RWD, AI/ML and Statistics: Next-Generation Evidence Synthesis
整合随机试验、真实世界数据、人工智能与统计学:下一代证据综合
Randomized controlled trials (RCTs)have been the cornerstone of clinical evidence; however, their cost, duration, and restrictive eligibility criteria limit power and external validity. Studies using real-world data (RWD), historically considered less reliable for establishing causality, are now recognized as an important source of real-world evidence (RWE). In parallel, artificial intelligence and machine learning (AI/ML) are increasingly used throughout the drug…